Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$160.79−0.31 (-0.19%)
Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –
Novartis Trade Payables: $4,456M in FY2025, down 2.5% from a year earlier. That is the lowest of the 8 years on record here.
Latest, FY2025
4,456
Period ended Dec 31, 2025
Change on a year earlier
-2.5%
4,572 in FY2024
History
8 years
Since FY2018
Sources
8
Documents cited below
Where the FY2025 figure comes from
“|| Trade payables | 4 243 | 4 456”
Source: Novartis Form 6-K (0001114448-26-000014) ↗
Reported in Form 6-K.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Trade Payables ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4,456 | -2.5% | Novartis Form 6-K (0001114448-26-000014) ↗ |
| FY2024 | Dec 31, 2024 | 4,572 | -7.2% | Novartis Form 6-K (0001114448-25-000003) ↗ |
| FY2023 | Dec 31, 2023 | 4,926 | -4.3% | Novartis Form 6-K (0001370368-24-000022) ↗ |
| FY2022 | Dec 31, 2022 | 5,146 | -7.3% | Novartis Form 6-K (0001370368-23-000068) ↗ |
| FY2021 | Dec 31, 2021 | 5,553 | +2.8% | Novartis Form 6-K (0001370368-22-000077) ↗ |
| FY2020 | Dec 31, 2020 | 5,403 | -0.4% | Novartis Form 6-K (0001370368-21-000072) ↗ |
| FY2019 | Dec 31, 2019 | 5,424 | -2.4% | Novartis Form 6-K (0001370368-20-000086) ↗ |
| FY2018 | Dec 31, 2018 | 5,556 | – | Novartis Form 6-K (0001370368-19-000062) ↗ |
Cite this data
StockData. (2026). Novartis Trade Payables ($M), annual FY2018–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/db-bs-ap
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.